← All stocks

ASML vs AVGO

ASML Holding N.V. New York Registry Shares vs Broadcom Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
ASML
AVGO
Composite score
Out of 100
74
71
Growth
80
100
Value
24
32
Quality
96
91
Momentum
97
61
Valuation
ASML
AVGO
Price
1711.32
362.66
Market cap
645.26B
1.73T
Trailing P/E
57.81
46.32
Forward P/E
27.86
19.05
EV / EBITDA
46.79
33.29
Dividend yield
0.5%
0.7%
Profitability
ASML
AVGO
ROE
53.9%
44.3%
Net margin
30.1%
42.9%
Debt / equity
0.22
0.80
Free cash flow
10.65B
26.91B
Growth
ASML
AVGO
Revenue growth (YoY)
21.3%
85.5%
Earnings growth (YoY)
28.5%
2.2%
Analyst target
2137.63
531.85
ACCE verdict

$AVGO edges out $ASML — but neither is cheap

$AVGO wins this matchup on growth and valuation trajectory. Its revenue surged 47.9% YoY and earnings exploded 85.4% YoY, earning a perfect Growth score of 100/100. More importantly, its forward P/E of 19.8x is dramatically lower than its trailing P/E of 59.9x, signaling rapid earnings normalization ahead. Analysts see 45.3% upside to a $523.73 target from the current $360.45.

$ASML is the higher-quality business on paper — ROE of 52.2% versus $AVGO's 37.3%, and a near-perfect Quality score of 96/100. Its Momentum score of 97/100 and a stunning +122.7% 1Y return reflect genuine market enthusiasm. But at a forward P/E of 48.5x on just 13.2% revenue growth, the valuation demands perfection. The 6-model fair value of $671.51 implies 62% downside from $1,769.32 — a sobering gap.

$AVGO's own 6-model fair value of $232.70 flags overvaluation too, but its 38.9% net margin and collapsing forward multiple make the risk/reward more defensible. $ASML's premium is harder to justify at current growth rates.

See full analysis